These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 35117879)

  • 21. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of outcomes in inflammatory breast cancer.
    Al Jarroudi O; El Bairi K; Abda N; Zaimi A; Jaouani L; Chibani H; Afqir S
    Biomark Med; 2021 Oct; 15(14):1289-1298. PubMed ID: 34486882
    [No Abstract]   [Full Text] [Related]  

  • 22. Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I-II gastric cancer.
    Sun X; Liu X; Liu J; Chen S; Xu D; Li W; Zhan Y; Li Y; Chen Y; Zhou Z
    Chin J Cancer; 2016 Jun; 35(1):57. PubMed ID: 27342313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic values of pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in endometrial cancer: a systematic review and meta-analysis.
    Ni L; Tao J; Xu J; Yuan X; Long Y; Yu N; Wu R; Zhang Y
    Arch Gynecol Obstet; 2020 Jan; 301(1):251-261. PubMed ID: 31768743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in laryngeal cancer: What should we expect from a meta-analysis?
    Hu X; Tian T; Sun Q; Jiang W
    Front Oncol; 2022; 12():945820. PubMed ID: 36033468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of the neutrophil-lymphocyte, platelet-lymphocyte and monocyte-lymphocyte ratio in breast cancer patients.
    Huszno J; Kolosza Z
    Oncol Lett; 2019 Dec; 18(6):6275-6283. PubMed ID: 31788105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
    Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M
    Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperative monocyte-to-lymphocyte ratio predicts recurrence in gastrointestinal stromal tumors.
    Cananzi FCM; Minerva EM; Samà L; Ruspi L; Sicoli F; Conti L; Fumagalli Romario U; Quagliuolo VL
    J Surg Oncol; 2019 Jan; 119(1):12-20. PubMed ID: 30426498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Revealing the prognostic landscape of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in metastatic castration-resistant prostate cancer patients treated with abiraterone or enzalutamide: a meta-analysis.
    Guan Y; Xiong H; Feng Y; Liao G; Tong T; Pang J
    Prostate Cancer Prostatic Dis; 2020 Jun; 23(2):220-231. PubMed ID: 32034294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic and predictive value of neutrophil-to-lymphocyte ratio after curative rectal cancer resection: A systematic review and meta-analysis.
    Hamid HKS; Davis GN; Trejo-Avila M; Igwe PO; Garcia-Marín A
    Surg Oncol; 2021 Jun; 37():101556. PubMed ID: 33819850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammation scores as prognostic biomarkers in small cell lung cancer: a systematic review and meta-analysis.
    Winther-Larsen A; Aggerholm-Pedersen N; Sandfeld-Paulsen B
    Syst Rev; 2021 Jan; 10(1):40. PubMed ID: 33509254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preoperative NLR and PLR in the middle or lower ESCC patients with radical operation.
    He YF; Luo HQ; Wang W; Chen J; Yao YW; Yan Y; Wu SS; Hu XX; Ke LH; Niu JY; Li HM; Ji CS; Hu B
    Eur J Cancer Care (Engl); 2017 Mar; 26(2):. PubMed ID: 26947428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The association of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio with retinal vein occlusion: a systematic review and meta-analysis.
    Liu Z; Perry LA; Penny-Dimri JC; Raveendran D; Hu ML; Arslan J; Britten-Jones AC; O'Hare F; Ayton LN; Edwards TL
    Acta Ophthalmol; 2022 May; 100(3):e635-e647. PubMed ID: 34219390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The Predictive Value of Perioperative Inflammatory Indicatorsin Prognosis of the Intrahepatic Cholangiocarcinoma Patients after Hepatectomy].
    Zhang ZF; Wang T; Kong JJ; Yang LP; Yang XW; Wang WT
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 May; 51(3):403-410. PubMed ID: 32543151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) as Possible Prognostic Markers for Patients Undergoing Resection of Adrenocortical Carcinoma.
    de Jong MC; Mihai R; Khan S
    World J Surg; 2021 Mar; 45(3):754-764. PubMed ID: 33221947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic roles of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in ovarian cancer: a meta-analysis of retrospective studies.
    Zhao Z; Zhao X; Lu J; Xue J; Liu P; Mao H
    Arch Gynecol Obstet; 2018 Apr; 297(4):849-857. PubMed ID: 29368160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of preoperative neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with glioma.
    Wang J; Xiao W; Chen W; Hu Y
    EXCLI J; 2018; 17():505-512. PubMed ID: 30034313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio associations with heart and body dose and their effects on patient outcomes in locally advanced non-small cell lung cancer treated with definitive radiotherapy.
    Xia WY; Zhu XR; Feng W; Liu J; Wang JM; Lv CX; Zhang Q; Yu W; Cai XW; Fu XL
    Transl Lung Cancer Res; 2020 Oct; 9(5):1996-2007. PubMed ID: 33209619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive Ability of Blood Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Gastrointestinal Stromal Tumors.
    Racz JM; Cleghorn MC; Jimenez MC; Atenafu EG; Jackson TD; Okrainec A; Venkat Raghavan L; Quereshy FA
    Ann Surg Oncol; 2015 Jul; 22(7):2343-50. PubMed ID: 25472648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are predictive of chemotherapeutic response and prognosis in epithelial ovarian cancer patients treated with platinum-based chemotherapy.
    Miao Y; Yan Q; Li S; Li B; Feng Y
    Cancer Biomark; 2016 Jun; 17(1):33-40. PubMed ID: 27314290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preoperative lymphocyte-monocyte ratio is not an independent prognostic factor in M0 (stage I-III) esophageal squamous cell carcinomas.
    Chen C; Chen G; Wu Y; Li J
    Transl Cancer Res; 2020 May; 9(5):3483-3490. PubMed ID: 35117713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.